NCT07090876View on ClinicalTrials.gov

Hemodynamic Effects of a Standardized Grape Seed Extract Supplementation

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

January 30, 2027

Study Completion Date

January 30, 2027

Conditions

High-normal Blood Pressure

Interventions

DIETARY_SUPPLEMENT

Standardized Grape Seed Extract

Grape seed dry extract standardized to provide: ≥95.0% of proanthocyanidins by spectrophotometry, ≥5.0% ≤15.0% of catechin and epicatechin by High-Performance Liquid Chromatography (HPLC)

OTHER

Placebo

Trial Locations (1)

Unknown

AOU Policlinico S.Orsola-Malpighi, Bologna

All Listed Sponsors

lead

Indena S.p.A

INDUSTRY

NCT07090876 - Hemodynamic Effects of a Standardized Grape Seed Extract Supplementation | Biotech Hunter | Biotech Hunter